Development of a Tissue Engineered Model of the Left Ventricle as a Platform for Personalized Heart Failure Therapies

开发左心室组织工程模型作为个性化心力衰竭治疗的平台

• 批准号: 473929
• 负责人: Khosravi Ramak
• 金额: $ 6.56万
• 依托单位: University Health Network (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-10-01 至 2024-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=473929&lang=en
• 关键词: Cardiothoracic Surgery; Cardiovascular Biomaterials; Congenital Heart Disease; Regenerative Medicine; Tissue Engineering

Heart failure is a serious and incurable condition that develops when the heart works less efficiently than it should and cannot pump blood to the rest of the body. Although it mostly affects adults, it can also occur in children who are born with heart d

心力衰竭是一种严重且无法治愈的疾病，当心脏工作效率低于应有水平时，无法将血液泵送到身体其他部位。虽然它主要影响成年人，但也可能发生在出生时患有心脏病的儿童中。